阿那莫林在中国上市了吗？好购买吗？

Anamulin is a targeted drug used to treat cancer cachexia. It was developed by Japan's Ono Pharmaceutical. It mainly targets weight loss and loss of appetite caused by malignant tumors such as non-small cell lung cancer and gastric cancer. For Chinese patients, it is crucial to understand the drug’s domestic availability, purchase channels, and therapeutic effects. This article will introduce in detail the marketing status of anamorelin in China, how to purchase it, and its efficacy in the treatment of cancer cachexia.

Is Anamorelin available on the market in China

The current listing status of Anamorelin in the Chinese market is the focus of many patients and family members. According to available information, the drug has not yet received formal approval from China's drug regulatory authorities.

Domestic Approval Status

As of now, Anamorelin has not passed the approval process of the China National Medical Products Administration and has not been officially marketed in China. The drug was approved by the US FDA in April 2021, but is still unapproved in China.

Domestic usage

Although it has not been officially launched, some medical institutions may provide the drug to patients through special channels. This situation is considered off-label medication and requires strict compliance with medical regulations and the principle of patient informed consent.

If Chinese patients need to use anamorelin, they usually need to obtain it through overseas drug purchase channels or participate in relevant clinical trial projects.

Is Anamorelin easy to buy?

Since Anamorelin is not officially launched in China, it is difficult to obtain Anamorelin, but there are still several feasible ways to purchase it.

Overseas drug purchase channels

Patients can purchase drugs from Japan, Laos and other countries that have approved marketing through formal cross-border medical service institutions. Ono Pharmaceutical's original drug Adlumiz and Laos Lucius's generic drug are the main options, with prices around US$463 and US$412 respectively.

Special channels for medical institutions

Hospitals in overseas listed countries may provide the drug to patients through international cooperation projects. This method requires a special application from the attending physician and complies with relevant medical management regulations.

Risk Tips for Purchasing Drugs

Purchasing through informal channels involves greater risks, including problems such as unguaranteed drug quality, inflated prices, and unqualified transportation conditions. Patients are advised to choose a qualified cross-border medical platform and verify the authenticity and validity of the medicines.

Complete drug traceability information should be provided when purchasing, including production batch number, original packaging and import certificate, etc.

Efficacy of Anamorelin

Anamulin shows unique pharmacological effects and clinical effects in the treatment of cancer cachexia. Its efficacy is mainly reflected in the following aspects.

Improve symptoms of cachexia

Clinical studies have shown that anamulin can significantly improve the symptoms of weight loss and loss of appetite in cancer patients, and a trend of weight stabilization or increase can be observed after taking the drug.

Targeted mechanism of action

As a GHS-R1a receptor agonist, anamulin directly stimulates the appetite center by simulating the effect of ghrelin, while promoting muscle protein synthesis and improving the patient's nutritional status.

Clinical use effects

In the treatment of cachexia in malignant tumors such as non-small cell lung cancer and gastric cancer, most patients report improved appetite after taking the drug, and the patient's weight is maintained or increased. The curative effect usually begins to appear after 2-3 weeks of medication.

The efficacy of Anamorelin is related to the patient's tumor type, disease stage and overall health status. It needs to be used individually under the guidance of a professional physician. The efficacy and safety indicators should be regularly evaluated during treatment.